Note 3 - Balance Sheet Components

3 Months Ended

Mar. 31, 2026

Notes to Financial Statements

Supplemental Balance Sheet Disclosures [Text Block]

3. Balance Sheet Components

Prepaid Expenses and Other Current Assets – Prepaid expenses and other current assets consist of the following:

	March 31, 2026		December 31, 2025
Prepaid clinical trial costs	$	832,889	$	1,197,679
Prepaid insurance premiums		110,045		165,067
Prepaid rent		25,974		16,000
Prepaid contract manufacturing costs		130,340		783,321
Other prepaid expenses		60,333		66,843
Total prepaid expenses and other current assets	$	1,159,581	$	2,228,910

Property and Equipment – Property and equipment consist of the following:

	March 31, 2026			December 31, 2025
Equipment and furnishings	$	512,437		$	512,437
Accumulated depreciation and amortization		(415,683	)		(403,607	)
Total property and equipment, net	$	96,754		$	108,830

Other Assets – Other assets consist of the following:

	March 31, 2026		December 31, 2025
Prepaid technology license fees	$	50,000	$	50,000
Deposits		19,947		36,947
Total other assets	$	69,947	$	86,947

Accrued Expenses – Accrued expenses consist of the following:

	March 31, 2026		December 31, 2025
Payroll-related liabilities	$	236,247	$	181,584
Accrued clinical trial costs		333,960		587,303
Other accrued expenses		93,000		113,929
Total accrued expenses	$	663,207	$	882,816